ANAshim Nandi

Ashim Nandi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ashim Nandi has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Overcoming polymerization of pyrroles under partially aqueous, aerobic, catalytic Fe( iii )-conditions to achieve oxidative cross-coupling with (hetero)arenes

    by Deepak Datta Gaonkar, Ashim Nandi, Rishikesh Narayan

    Herein, we report an elusive oxidative cross-coupling of pyrroles with furans and other heteroaryls under Earth-abundant, metal-catalyzed, partially aqueous aerial conditions while circumventing the polymerization of pyrroles.

  • Systematic Modeling of Covalent Inhibitors of SARS-CoV-2 Main Protease and Its Mutants

    by Pan-Pan Chen, Ashim Nandi, Arieh Warshel

    The SARS-CoV-2 main protease (Mpro) is a key antiviral target due to its essential role in viral replication and the absence of close human homologues. Covalent inhibitors, which form durable bonds with critical active-site residues have shown particular promise for viral proteases, combining high potency with prolonged suppression of enzymatic activity. Among these, the aldehyde-based inhibitor H102 exhibits nanomolar inhibition of Mpro (IC50 = 8.8 nM), outperforming other reported inhibitors such as GC376 and the clinically approved nitrile-based inhibitor PF-07321332. Despite its potency, the threat of viral mutations raises concerns about the robustness of covalent inhibitors against drug resistance. In this study, we employ ab initio and empirical valence bond (EVB) simulations to elucidate the covalent binding mechanism of H102, revealing that a water-assisted concerted nucleophilic attack and proton transfer (PT-NA) dominates the reaction pathway via a single transition state, with a calculated overall activation free energy of ~20.5 kcal/mol, in good agreement with experimental kinetics (ΔG‡ = 21.3 kcal/mol). Although the crystal structure of H102 bound to Mpro displays an unusual distortion of the catalytic dyad, in which the P2 benzyl group forms a “sandwich-like” arrangement between Cys145 and His41, our simulations indicate that this distortion arises after covalent bond formation. The catalytic dyad remains structurally intact during the reaction, suggesting that the crystallographic pose reflects post-reaction conformational relaxation rather than the reaction mechanism itself. Furthermore, we successfully predict the absolute binding free energies (ABFEs) of H102 and its analogues across wild-type and mutant Mpro variants, accurately reproducing experimental affinities and providing quantitative insight into how mutations impact inhibitor potency. Collectively, these findings not only elucidate the mechanistic basis of aldehyde-based covalent inhibition but also highlight the utility of ABFE-guided computational strategies in the rational design of potent, mutation-resilient antiviral therapeutics.

  • Combating Antiviral Drug Resistance: A Multipronged Strategy

    by Jiao Zhou, Ashim Nandi, Yan Xu, Jing An, Arieh Warshel, Ziwei Huang

    ConspectusViral proteases are essential enzymes required for viral replication and assembly, making them prime antiviral drug targets. However, under the selective pressure of protease inhibitors, viruses can acquire mutations that reduce drug binding efficacy, posing significant challenges in both chronic infections (e.g., HIV, HCV) and acute infections like COVID-19, where mutations in the SARS-CoV-2 main protease (Mpro) have been reported to compromise the efficacy of drugs such as nirmatrelvir. To address these challenges, mainstream strategies in combating viral protease drug resistance mutations include combination therapies and targeting evolutionarily conserved regions of viral proteases. By disrupting multiple stages of the viral lifecycle or focusing on functionally indispensable residues, these strategies aim to develop next-generation antivirals that remain effective against evolving viral mutations.Here we provide an account of our laboratory's journey with our collaborators of the past 5 years, started during the COVID-19 pandemic and continued beyond it, in developing a multipronged strategy to combat antiviral drug resistance. The journey began with the discovery of compound 17 from screening our in-house α-ketoamide library with inhibitory activity against both the proteasome and SARS-CoV-2. We subsequently designed more specific covalent Mpro inhibitors with different warheads, such as H135 and H102 displaying potent activity, using computational and structural insights. H135 exhibited broad anti-SARS-CoV-2 activity, including alpha, delta, XBB.1.5, BA.5.2, EG.5.1, and JN.1.1 variants, in VeroE6-TMPRSS2 cells. Particularly, we observed an unusual distortion of the geometry of the catalytic dyad of Mpro in the X-ray crystal structure of H102, in which H102 induced conformational change of the catalytic residue His41. Using H102 as a model compound, we demonstrated that inducing conformational changes in His41 slightly enhances the antiresistance profile of inhibitors. Besides conventional protease inhibition, we attempted a new alternative strategy of protease degradation and developed HP211206, the first reported PROTAC molecule targeting SARS-CoV-2 Mpro, which is capable of degrading known drug-resistant Mpro mutants. To aid the design of these viral protease inhibitors and degraders, computational chemistry was used to develop an efficient method integrating the PDLD/S-LRA/β framework with quantum-mechanical calculations to evaluate both non-covalent and covalent contributions to absolute binding free energy between protein mutants and various inhibitors, which can help find inhibitors or degraders with high target binding. A vitality strategy was also employed to evaluate both the binding free energy of inhibitors (Ki) and the enzyme's catalytic efficiency parameters (kcat and KM) for natural substrates, which can help predict sites on the viral protease prone to drug resistance mutations and thus to be avoided in drug targeting. Additionally, a kinetic simulation framework was used to model the time dependence of inhibition (IC50(t)) for nirmatrelvir analogues, providing valuable insights into their time-dependent efficacy. Most recently, artificial intelligence was applied in the development of D2Screen, which incorporates deep learning into conventional virtual screening and enabled us to identify quinoline-based non-covalent Mpro inhibitors exhibiting anti-drug-resistance activity against the E166V Mpro mutant. Together, these synthetic, computational, structural, and biological studies illustrate a multipronged strategy for developing more effective therapeutics that are less susceptible to drug resistant mutation.


  • Role of Quantum Tunneling in Synthetic Organic Chemistry

    by Tim Schleif, Ashim Nandi

    Quantum mechanical tunneling offers an alternative dynamical pathway to the classical (thermal) overcoming of energetic barriers, by penetrating these barriers instead. Recent years have shed light on its impact on organic synthesis in terms of kinetics, reaction outcomes, and lifetimes (and thus feasibility) of reactive intermediates or supposedly stable products. This concept article summarizes recent computational and experimental studies and illuminates how the insights from these studies, for example, regarding the concepts of tunneling control and instability, should inform synthesis design and optimization.


  • The Action of Plastic Degrading Enzyme Is Accelerated Mainly Due to an Increase in Thermal Stability Rather Than by an Inherent Catalytic Effect

    by Ashim Nandi, Arieh Warshel

    Polyethylene terephthalate (PET) hydrolases offer a promising enzymatic route to plastic waste degradation under mild conditions. Among these, the engineered FAST-PETase variant exhibits superior catalytic efficiency and thermostability compared to the wild-type IsPETase, yet the molecular origins of these enhancements remain debated. In this work, we employ empirical valence bond simulations in conjunction with semimacroscopic PDLD/S-LRA calculations to investigate the rate-determining acylation step in PET dimer hydrolysis catalyzed by both wild-type and FAST-PETase. Our results successfully reproduce the experimentally observed trend in catalytic rate enhancement between the two systems. While prior interpretations attribute the improved activity to a strengthened hydrogen-bond network involving Asp106 and His237, we demonstrate that the distal N233K mutation in FAST-PETase induces long-range electrostatic changes that enhance catalytic efficiency by modulating the active site dipolar environment. More importantly, we show that the elevated performance of FAST-PETase at higher temperatures is not due to reduced flexibility in the mutant region but arises from enhanced thermal stability, which allows the enzyme to operate effectively at elevated temperatures and thus accelerate reaction rates. These findings underscore the central role of electrostatics and stability in enzyme engineering and suggest that data-driven methods, such as maximum entropy models, may enable the rational identification of further stability-enhancing mutations for improved PET depolymerization.


  • Open Access

    The Action of Plastic Degrading Enzyme is Accelerated Mainly Due to an Increase in Thermal Stability Rather Than by Inherent Catalytic Effect

    by Ashim Nandi, Arieh Warshel

    Polyethylene terephthalate (PET) hydrolases offer a promising enzymatic route to plastic waste degradation under mild conditions. Among these, the engineered FAST-PETase variant exhibits superior catalytic efficiency and thermostability compared to the wild-type IsPETase, yet the molecular origins of these enhancements remain debated. In this work, we employ empirical valence bond (EVB) simulations in conjunction with semi-macroscopic PDLD/S-LRA calculations to investigate the rate-determining acylation step in PET dimer hydrolysis catalyzed by both wild-type and FAST-PETase. Our results successfully reproduce the experimentally observed trend in catalytic rate enhancement between the two systems. While prior interpretations attributing the improved activity to a strengthened hydrogen-bond network involving Asp106 and His237, we demonstrate that the distal N233K mutation in FAST-PETase induces long-range electrostatic changes that enhance catalytic efficiency by modulating the active site dipolar environment. More importantly, we show that the elevated performance of FAST-PETase at higher temperatures is not due to reduced flexibility in the mutant region but arises from enhanced thermal stability, which allows the enzyme to operate effectively at elevated temperatures and thus accelerate reaction rates. These findings underscore the central role of electrostatics and stability in enzyme engineering and suggest that data-driven methods, such as maximum entropy models, may enable the rational identification of further stability-enhancing mutations for improved PET depolymerization.

  • Open Access

    Role of Quantum Tunneling in Synthetic Organic Chemistry

    by Tim Schleif, Ashim Nandi

    Quantum mechanical tunneling offers an alternative pathway to the classical (thermal) overcoming of energetic barriers, by penetrating these barriers instead. Recent years have shed light on its impact on organic synthesis in terms of kinetics, reaction outcomes and lifetimes (and thus feasibility) of reactive intermediates or supposedly stable products. This concept article summarizes recent computational and experimental studies and illuminates how the insights from these studies, e.g. regarding the concepts of tunneling control and instability, should inform synthesis design and optimization.

  • Mechanistic Insights into Nitrile and Alkyne Covalent Inhibitors of the SARS-CoV-2 Main Protease

    by Ashim Nandi, Mojgan Asadi, Aoxuan Zhang, Zhen T. Chu, Arieh Warshel

    The treatment of SARS-CoV-2 can be accomplished by effective suppression of its 3CL protease (3CLpro), also known as the main protease (Mpro) and nonstructural protein 5 (nsp5). Covalent inhibitors can irreversibly and selectively disable the protease, particularly when they are highly exothermic. Herein we investigated the distinct kinetic behaviors exhibited by two covalently linked SARS-CoV-2 inhibitors. One of these inhibitors features a nitrile reactive group, while the other has this group replaced by an alkyne group, a less reactive electrophile. Our investigations involve the assessment of the free energy surfaces of the key feasible mechanisms: that is, direct and water-assisted mechanisms involved in the rate-determining proton-transfer nucleophilic attack step through the utilization of both ab initio and empirical valence bond (EVB) simulations. The calculated free energy profiles show that substituting the nitrile group with alkyne increases the chemical barrier but leads to very exothermic reaction energy and is an irreversible process as opposed to nitrile, which is moderately exothermic and reversible. We also examine the time dependence of IC50 inhibition by applying an innovative kinetic simulation approach, which is particularly important in studies of covalent inhibitors with a very exothermic bonding step. Our computational approach provides a good agreement between the calculated and observed values of the time dependence results for the nitrile and alkyne inhibitors. Our approach, which is rather unique in combining calculations of the chemical barriers and the binding energy is likely to be very effective in studies of the effectiveness of other covalent inhibitors related cases.


  • Exploring the Light-Emitting Agents in Renilla Luciferases by an Effective QM/MM Approach

    by Ashim Nandi, Aoxuan Zhang, Zhen Tao Chu, Wen Jun Xie, Zhongxin Xu, Suwei Dong, Arieh Warshel

    Bioluminescence is a fascinating natural phenomenon, wherein organisms produce light through specific biochemical reactions. Among these organisms, Renilla luciferase (RLuc) derived from the sea pansy Renilla reniformis is notable for its blue light emission and has potential applications in bioluminescent tagging. Our study focuses on RLuc8, a variant of RLuc with eight amino acid substitutions. Recent studies have shown that the luminescent emitter coelenteramide can adopt multiple protonation states, which may be influenced by nearby residues at the enzyme's active site, demonstrating a complex interplay between protein structure and bioluminescence. Herein, using the quantum mechanical consistent force field method and the semimacroscopic protein dipole-Langevin dipole method with linear response approximation, we show that the phenolate state of coelenteramide in RLuc8 is the primary light-emitting species in agreement with experimental results. Our calculations also suggest that the proton transfer (PT) from neutral coelenteramide to Asp162 plays a crucial role in the bioluminescence process. Additionally, we reproduced the observed emission maximum for the amide anion in RLuc8-D120A and the pyrazine anion in the presence of a Na+ counterion in RLuc8-D162A, suggesting that these are the primary emitters. Furthermore, our calculations on the neutral emitter in the engineered AncFT-D160A enzyme, structurally akin to RLuc8-D162A but with a considerably blue-shifted emission peak, aligned with the observed data, possibly explaining the variance in emission peaks. Overall, this study demonstrates an effective approach to investigate chromophores' bimolecular states while incorporating the PT process in emission spectra calculations, contributing valuable insights for future studies of PT in photoproteins.


  • Open Access

    Computational Mechanistic Insights into Reversible and Irreversible Covalent Inhibitors Targeting SARS-CoV-2 Mpro

    by Mojgan Asadi, Ashim Nandi, Arieh Warshel

    The treatment of SARS-CoV-2 can be accomplished by an effective suppression of its 3CL protease (3CLpro), also known as the main protease (Mpro) and nonstructural protein 5 (nsp5). Covalent inhibitors can irreversibly and selectively disable the protease, particularly when they are highly exothermic. Herein we delve into the distinct kinetic behaviors exhibited by two covalently linked SARS-CoV-2 inhibitors. One of these inhibitors features a nitrile reactive group, while the other has this group replaced by an alkyne group, a less reactive electrophile. Our investigations involve the assessment of pertinent free energy surfaces through the utilization of both ab initio and empirical valence bond (EVB) simulations. The calculated free energy profiles show that substituting the nitrile group with alkyne significantly increases the overall reaction exothermicity. This leads to an efficient inhibition, even though the reaction of the nitrile group has a substantially lower barrier than the alkyne group. We examine the time-dependence of IC50 inhibition by applying a novel kinetic simulation approach, which is particularly important in studies of covalent inhibitors with a very exothermic bonding step. Our computational approach reproduces the observed binding kinetics and appears to provide a powerful tool for studies of covalent inhibitors.